CXCL10 and neoplasm: The co-injection of two oncolytic adenoviruses encoding CXCL10 and IL-18 into established tumours resulted in reduced tumour growth in a mouse myeloma tumour model, with complete tumour regression in 80% of the mice, although CXCL10 virus injection alone only slowed the tumour growth, without complete regression.